Stock Name: EuYanSang
Company Name: EU YAN SANG INTERNATIONAL LTD
DMG & Partners Research in a Mar 27 research report says: "Eu Yan Sang has managed to overcome a major hurdle in China. It has clinched a key license to open a pharmacy in China which will allow it to sell its prescriptions drugs and Chinese herbal medicine.
"Previously, the Company was only retailing food products and its proprietary Lingzhi cracked spores capsules in China. Its flagship products such as Bak Foong pills are considered “medicine”, and hence could only be distributed via hospitals.
"The first pharmacy will open in Dongguan later this year, and a second one is being planned. The pharmacy license is awarded on a store by store basis. EYS has just opened its 16th store in the country and targets 20 by year end. Target price of 94 cents. MAINTAIN BUY."
Company Name: EU YAN SANG INTERNATIONAL LTD
| Research House: DMG | Price Call: BUY | Target Price: 0.94 |
DMG & Partners Research in a Mar 27 research report says: "Eu Yan Sang has managed to overcome a major hurdle in China. It has clinched a key license to open a pharmacy in China which will allow it to sell its prescriptions drugs and Chinese herbal medicine.
"Previously, the Company was only retailing food products and its proprietary Lingzhi cracked spores capsules in China. Its flagship products such as Bak Foong pills are considered “medicine”, and hence could only be distributed via hospitals.
"The first pharmacy will open in Dongguan later this year, and a second one is being planned. The pharmacy license is awarded on a store by store basis. EYS has just opened its 16th store in the country and targets 20 by year end. Target price of 94 cents. MAINTAIN BUY."
No comments:
Post a Comment